Skip directly to Accessibility Notice

EMRIX
Emerging Markets Fund - Class I

Market Updates*

  • The availability of vaccines and actual vaccination rates have generally surpassed expectations from a few months ago, but many emerging markets (and some developed markets, such as Japan) were starting from low levels of achieved vaccination.
  • The inflation debate is about long-run expectations where the outlook is much less clear, as secular forces of debt, demographics and digitization may conspire to keep generalized inflation low.
  • Northeast Asia dominates fabrication of certain areas of semiconductors.1

Learn More | Normalization and Change at the Same Time

1Source: BGC, UBS. Data as of 2019.

Market Updates*

  • The availability of vaccines and actual vaccination rates have generally surpassed expectations from a few months ago, but many emerging markets (and some developed markets, such as Japan) were starting from low levels of achieved vaccination.
  • The inflation debate is about long-run expectations where the outlook is much less clear, as secular forces of debt, demographics and digitization may conspire to keep generalized inflation low.
  • Northeast Asia dominates fabrication of certain areas of semiconductors.1

Learn More | Normalization and Change at the Same Time

1Source: BGC, UBS. Data as of 2019.

Daily Price as of 09/20/21

NAV DAILY CHANGE
$21.20 $-0.55 / -2.53%

Class I Details: EMRIX

INCEPTION DATE GROSS/NET EXPENSES1
1.12%/1.00%
Why Invest?
Click here to read the EME White paper - The Electric Vehicle
Revolution and ESG Charge Ahead
Click here to read the EME Whitepaper - The Electric Vehicle
Revolution and ESG Charge Ahead

Latest Commentary

By: David Semple, Portfolio Manager

The Emerging Markets Fund commentary includes a review of the prominent emerging market trends over the previous quarter, a look at the key drivers of Fund performance, and an update on current Fund positioning.

Download David's Commentary

Additional Resources

                                                                                                                                            

Video Viewpoint

Emerging Markets Outlook for 2021

David Semple, Ola El-Shawarby, CFA
Portfolio Manager, VanEck Emerging Markets Equity, Senior Analyst, VanEck Emerging Markets Equity

VanEck Emerging Markets Equity Portfolio Manager, David Semple, and Emerging Markets Equity Strategy Senior Analyst, Ola El-Shawarby, discuss the 2021 outlook for and effects of digitization on emerging markets.

View now


Emerging Markets: Rebound and Growth Opportunities

David Semple
Portfolio Manager

Portfolio Manager David Semple shares his outlook for emerging markets through the end of the year, including growth expectations for China. He also discusses one of the companies he’s most excited to watch heading into 2021: WuXi Biologics.

View now


What Bifurcation in China and LatAm Means for Investors

David Semple
Portfolio Manager, Emerging Markets Equity Strategy

Portfolio Manager David Semple offers his views on how U.S.-China relations may impact investors, our approach to investing in Latin America and highlighted structural growth companies in our strategy.

View now


Acceleration and Divergence in Emerging Markets Amid COVID-19

David Semple
Portfolio Manager

Portfolio Manager David Semple shares his views on how the COVID-19 pandemic is impacting investing in emerging markets. He highlights companies and sectors well-positioned in the current environment, as well as those facing new challenges.

View now


Emerging Markets Equity: Harnessing Growth

David Semple
Portfolio Manager

View now


Emerging Markets Equity: Focus on Structural Growth, Not Headline Hysteria

David Semple
Portfolio Manager

VanEck Emerging Markets Equity Portfolio Manager David Semple discusses investment opportunities with visible and persistent growth that survive and thrive in a rapidly changing asset class.

View now